Product Images Tikosyn

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Tikosyn NDC 69189-5800 by Avera Mckennan Hospital, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Dofetilide 0.125 mg capsule - 6918958001

Dofetilide 0.125 mg capsule - 6918958001

DOFETILIDE, also known as TIKOSYN, is a medication manufactured by PFIZER available in 0.125 MG capsules. The lot number for the manufacturing is N30313, and the lot number assigned by the hospital is APF16F28-AL. The expiration date of this medication is 06/28/2017. The National Drug Code assigned for this medication is 6918958001. This medication is associated with AVERA MCKENNAN hospital.*

Chemical Structure - tikosyn 01

Chemical Structure - tikosyn 01

figure 1 - tikosyn 02

figure 1 - tikosyn 02

This is a table displaying the mean change from baseline in QTc (in milliseconds) on both day 1 and day 23 (steady state) with varying mean plasma dofetilide concentrations (in ng/mL).*

figure 2 - tikosyn 03

figure 2 - tikosyn 03

figure 3 - tikosyn 04

figure 3 - tikosyn 04

This appears to be a table of data, with three different dosage levels of a medication (125 BID Dofetide, 250 BID Dofetide, and 500 BID Dofetide) and corresponding p-values from a Log Rank Test with Placebo. The data includes a footnote indicating that "T" represents "Treatment" and "o" represents "Events" (the number of occurrences being measured). The table also has a time axis in months. Without additional context it is unclear what the medication is used for or the purpose of the study.*

figure 4 - tikosyn 05

figure 4 - tikosyn 05

This appears to be a chart or table showing different doses of a medication called Dofetilide being administered at different frequencies (BID = twice a day) and their corresponding p-values (statistical significance) in relation to a placebo. The time axis at the bottom indicates that the study or analysis was conducted for a period of 12 months. However, without further context or information, the purpose and interpretation of the chart/table is not clear.*

flow chart - tikosyn 06

flow chart - tikosyn 06

This is a medication guideline that provides instructions on the use of Dofetilide in patients with a predetermined creatinine clearance (Clcr) level. It advises against the use of Dofetilide if the Clcr is below 20mL/min and provides dosage amounts for various Clcr ranges. The text also recommends monitoring the patient's QT interval and discontinuing the medication if the QT interval increases by 500 msec or more.*

Logo - tikosyn 07

Logo - tikosyn 07

This text provides information about the distributor of a product manufactured by Pfizer Labs. The name of the distributor is Pfizer Inc and it is located in NY, NY 10017.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.